Your browser doesn't support javascript.
loading
GBP2 serves as a novel prognostic biomarker and potential immune microenvironment indicator in renal cell carcinoma.
Tian, Yijun; Wang, Hongru; Guan, Wenbin; Tu, Xiaohua; Zhang, Xiangmin; Sun, Ye; Qian, Cheng; Song, Xu; Peng, Bo; Cui, Xingang.
Afiliación
  • Tian Y; Department of Urinary Surgery, The Third Affiliated Hospital of Naval Medical University (Eastern Hepatobiliary Surgery Hospital), Shanghai, China.
  • Wang H; Department of Urinary Surgery, The Third Affiliated Hospital of Naval Medical University (Eastern Hepatobiliary Surgery Hospital), Shanghai, China.
  • Guan W; Department of Pathology, Xinhua Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.
  • Tu X; Department of Blood Transfusion, First Affiliated Hospital of Naval Medical University, Shanghai, China.
  • Zhang X; Department of Urinary Surgery, Luodian Hospital, Shanghai, China.
  • Sun Y; Department of Urinary Surgery, Postgraduate Training Base in Shanghai Gongli Hospital, Ningxia Medical University, Yinchuan, Ningxia, China.
  • Qian C; Department of Urinary Surgery, Postgraduate Training Base in Shanghai Gongli Hospital, Ningxia Medical University, Yinchuan, Ningxia, China.
  • Song X; Department of Urology, Shanghai Seventh People's Hospital, Shanghai, China.
  • Peng B; Department of Urology, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, China.
  • Cui X; Department of Urinary Surgery, The Third Affiliated Hospital of Naval Medical University (Eastern Hepatobiliary Surgery Hospital), Shanghai, China.
Mol Carcinog ; 61(12): 1082-1098, 2022 12.
Article en En | MEDLINE | ID: mdl-36222186

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Neoplasias Renales Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Revista: Mol Carcinog Asunto de la revista: BIOLOGIA MOLECULAR / NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Neoplasias Renales Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Revista: Mol Carcinog Asunto de la revista: BIOLOGIA MOLECULAR / NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: China